0001104659-16-139279.txt : 20160812
0001104659-16-139279.hdr.sgml : 20160812
20160812131908
ACCESSION NUMBER: 0001104659-16-139279
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160810
FILED AS OF DATE: 20160812
DATE AS OF CHANGE: 20160812
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gemphire Therapeutics Inc.
CENTRAL INDEX KEY: 0001638287
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472389984
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 43334 7 MILE ROAD
STREET 2: SUITE 1000
CITY: NORTHVILLE
STATE: MI
ZIP: 48167
BUSINESS PHONE: 248-980-6538
MAIL ADDRESS:
STREET 1: 43334 7 MILE ROAD
STREET 2: SUITE 1000
CITY: NORTHVILLE
STATE: MI
ZIP: 48167
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LICHTINGER PEDRO
CENTRAL INDEX KEY: 0001470741
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37809
FILM NUMBER: 161827439
MAIL ADDRESS:
STREET 1: 1301 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
4
1
a4.xml
4
X0306
4
2016-08-10
0
0001638287
Gemphire Therapeutics Inc.
GEMP
0001470741
LICHTINGER PEDRO
43334 SEVEN MILE ROAD
SUITE 1000
NORTHVILLE
MI
48167
1
0
0
0
Common Stock
2016-08-10
4
C
0
39274
6.7059
A
39274
D
Common Stock
2016-08-10
4
P
0
10000
10.00
A
49274
D
8% Convertible Subordinated Promissory Note
6.7059
2016-08-10
4
C
0
250000
0
D
Common Stock
39274
0
D
The note was issued in the original principal amount of $250,000. The outstanding principal and $13,370 of accrued interest on the note automatically converted into shares of Common Stock immediately prior to the closing of the Company's initial public offering.
/s/ Stephanie Swan, by Power of Attorney
2016-08-12